Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.

Indian journal of pathology & microbiology - 1 Jan 2000

Dave Rutvi G, Geevar Tulasi, Mammen Joy J, Vijayan Ramya, Mahasampath Gowri, Nair Sukesh C

Abstract excerpt

CONTEXT: Hemophilia A is classified as mild, moderate, and severe based on Factor VIII levels (FVIII). Clot-based assays only detect initiation of thrombin generation, hence FVIII levels may not accurately predict the bleeding risk in all hemophilia patients. The entire process of thrombin generation as measured by global hemostasis tests like activated partial thromboplastin time clot waveform analysis (APTT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Hemophilia A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemorrhage

Share to Partial Thromboplastin Time

Share to Phenotype

Share to ROC Curve

Share to Thrombin

Share to Thrombosis

Source

Identifiers

PMID: 33433420
DOI: 10.4103/IJPM.IJPM_336_19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.PMID 33433420Read ↗

Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype.Semantic proximity Read ↗

Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation.Semantic proximity Read ↗

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease.Semantic proximity Read ↗

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.Semantic proximity Read ↗

Tests of global haemostasis and their applications in bleeding disorders.Semantic proximity Read ↗

Bleeders, bleeding rates, and bleeding score.Semantic proximity Read ↗

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia.Semantic proximity Read ↗

Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets.Semantic proximity Read ↗

Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.Semantic proximity Read ↗

A cross-sectional study of bleeding phenotype in haemophilia A carriers.Semantic proximity Read ↗

Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype.Semantic proximity Read ↗

Delphi Consensus Recommendations for the Definition of a Severe Bleeding Phenotype and Initiation of Prophylaxis in Patients With Non-Severe Haemophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.